Corpus ID: 73496320

Who Knows What, and When?: A Survey of the Privacy Policies Proffered by U.S. Direct-to-Consumer Genetic Testing Companies.

@article{Hazel2018WhoKW,
  title={Who Knows What, and When?: A Survey of the Privacy Policies Proffered by U.S. Direct-to-Consumer Genetic Testing Companies.},
  author={James W Hazel and Christopher Slobogin},
  journal={Cornell journal of law and public policy},
  year={2018},
  volume={28 1},
  pages={
          35-66
        }
}
  • J. Hazel, C. Slobogin
  • Published 19 April 2018
  • Business, Medicine
  • Cornell journal of law and public policy
Direct-to-consumer genetic testing (DTC-GT) companies have proliferated in the past several years. Based on an analysis of genetic material submitted by consumers, these companies offer a wide array of services, ranging from providing information about health and ancestry to identification of surreptitiously-gathered biological material sent in by suspicious spouses. Federal and state laws are ambiguous about the types of disclosures these companies must make about how the genetic information… Expand

Topics from this paper

Genetic Privacy and Data Protection: A Review of Chinese Direct-to-Consumer Genetic Test Services
TLDR
The Chinese DTC genetic testing business is running in a regulatory vacuum, governed by self-regulation, and the government should develop a comprehensive legal framework to regulate D TC genetic testing offerings. Expand
Who’s on third? Regulation of third-party genetic interpretation services
TLDR
The scope of federal jurisdiction over third-party genetic interpretation services—while limited—could be appropriate at this time, subject to agency clarification and appropriate exercise of oversight. Expand
In Genes We Trust: Genetic Privacy in the Age of Precision Medicine
Rapid development in the area of precision medicine in recent decades has prompted a number of questions and concerns, despite its high promises. The field is charting new territory, not just forExpand
From proband to provider: is there an obligation to inform genetic relatives of actionable risks discovered through direct-to-consumer genetic testing?
TLDR
It is argued for a shift in responsibility from proband to provider, placing a duty on test providers in the event of identified actionable risks to relatives, where the risk of disease to a relative is actionable and providers ought to share results even in the face of the proband's objections. Expand
Genetic Data: Potential Uses and Misuses in Marketing
TLDR
The authors propose a framework that incorporates genetic influences into existing consumer behavior theory and use it to survey potential marketing uses of genetic data, which include business strategies that rely on genetic variants as bases for segmentation and targeting and refinement of consumer theory by uncovering biological mechanisms underlying behavior. Expand
Genetic Data: Potential Uses and Misuses in Marketing
Advances in molecular genetics have led to the exponential growth of the direct-to-consumer genetic testing industry, resulting in the assembly of massive privately-owned genetic databases. ThisExpand
Genetic Data Aren't So Special: Causes and Implications of Reidentification.
TLDR
While patients and research participants need to be more aware of pervasive data-sharing practices, consent forms are the wrong place to provide this education and health systems should engage with patients throughout patient care to educate them about data- sharing practices. Expand
What motivates the sharing of consumer-generated genomic information?
TLDR
This commentary discusses consumers three scenarios: satisfying personal curiosity, providing a social good, and receiving a financial return, which can be examined to determine how various stakeholders, such as consumers, might prefer to extract value from genomic information. Expand
Third-Party Genetic Interpretation Tools: A Mixed-Methods Study of Consumer Motivation and Behavior.
TLDR
Survey of raw data access and third-party tool usage among DTC customers recruited through social media suggests that even when initially motivated by ancestry and genealogy, consumers frequently also pursue health information in a largely unregulated and expanding suite of third- party tools, raising both challenges and opportunities for the professional genetics community. Expand
Game theory for privacy-preserving sharing of genomic data
TLDR
This chapter reviews recent advancements in genomic data privacy that rely on game-theoretic approaches, while characterizing their core contributions, as well as their limitations. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 13 REFERENCES
Is Privacy Policy Language Irrelevant to Consumers?
This article reports the results of two experiments in which large, census-weighted samples of Americans read short excerpts from Facebook’s, Yahoo’s, and Google’s privacy policies, which are atExpand
Third party interpretation of raw genetic data: an ethical exploration
TLDR
It is found that many of the ethical concerns previously described in DTC-GT also applied to TPI websites, including inadequate informed consent, questionable clinical validity and utility, and lack of medical supervision. Expand
A comparative study of online privacy policies and formats
TLDR
It was found participants were not able to reliably understand companies’ privacy practices with any of the formats, and participants were faster with standardized formats but at the expense of accuracy for layered policies, and Privacy Finder formats supported accuracy more than natural language for harder questions. Expand
The Failure of Fair Information Practice Principles
Modern data protection law is built on "fair information practice principles." At their inception in the 1970s and early 1980s, FIPPS were broad, aspirational, and included a blend of substantiveExpand
Regulatory controls for direct-to-consumer genetic tests: a case study on how the FDA exercised its authority
In February 2015, 23andMe received clearance from the United States Food and Drug Administration (FDA) for a carrier status test for a gene linked to Bloom syndrome. This was the first FDAExpand
Strategies for reducing online privacy risks: Why consumers read (or don’t read) online privacy notices
TLDR
It is found that reading privacy notices is related to concern for privacy, positive perceptions about notice comprehension, and higher levels of trust in the notice, suggesting that effective privacy notices serve an important function in addressing risk issues related to e-commerce. Expand
GINA, genetic discrimination, and genomic medicine.
Has the Genetic Information Nondiscrimination Act succeeded in its twin missions of preventing discrimination and alleviating public fears about the potential for discrimination on the basis ofExpand
Milne & Mary J . Culnan , Strategies for Reducing Online Privacy Risks : Why Consumers Read ( or Don ’ t Read ) Online Privacy Notices , 18 J
  • 2016
Shedding Privacy Along with our Genetic Material: What Constitutes Adequate Protection against Surreptitious Genetic Testing? 18 AMA
  • J. ETHICS
  • 2016
The Ethical, Legal, and Social Implications Program of the National Human Genome Research Institute: Reflections on an Ongoing Experiment, 15 ANN. REV. OF GENOMICS AND HUM
  • GENETICS
  • 2014
...
1
2
...